HC Wainwright reissued their buy rating on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $425.00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback